ResMed Inc. announced unaudited consolidated earnings results for the second quarter and six months ended December 31, 2011. For the quarter, the company reported net revenue of $332,738,000 against $305,986,000 a year ago. Income from operations was $67,254,000, income before income taxes was $82,931,000 and net income was $62,872,000 or $0.42 per diluted share compared to income from operations of $69,873,000, income before income taxes of $78,921,000 and net income of $58,456,000 or $0.37 per diluted share a year ago. Cash flow from operations was $110.6 million. Capital expenditure for the quarter was $12.3 million. For the six months, the company reported net revenue of $647,513,000 against $587,998,000 a year ago. Income from operations was $128,129,000, income before income taxes was $149,428,000 and net income was $113,390,000 or $0.75 per diluted share compared to income from operations of $136,266,000, income before income taxes of $155,474,000 and net income of $115,164,000 or $0.73 per diluted share a year ago. Looking-forward for the balance of fiscal year 2012, the company expects to have gross margins to be in the range of 58% to 60%, assuming current exchange rates. Looking forward, the company estimates its effective tax rate for fiscal year 2012 will also be in the vicinity of 24%.